Walk to a range of innovation hubs in less than 5 minutes. UCLA’s compact, walkable campus enables experts across disciplines to share facilities, equipment, and most importantly, conversations that lead to synergistic discoveries.
Innovation Lives Here
It's a 5 minute or less walk from our location to any of the following innovation centers on campus. Your next collaboration is right down the street.
Terasaki Life Sciences Building
California Nanosystems Institute
Biomedical Sciences Research Building
Henry Samueli School of Engineering
Neuroscience Research Building
Nearly 75,000 employees and students commute to UCLA on a regular basis.
UCLA Transportation strives to provide smart and sustainable commute options for students, staff and faculty by offering discounted public transit passes, bicycle incentive programs, vanpool programs, carpool parking discounts and more. By embracing a low-car or car-free lifestyle, staff and faculty support UCLA's efforts to create a vibrant, sustainable and healthy campus.
Whether you are on campus or in the surrounding Westwood area, there is plenty to do and explore.
Faculty Research Interests
Our accomplished faculty members collaborate on a wide spectrum of research interests covering everything from the genetic basis of complex traits to computational methods for understanding genetic risk factors for common diseases.
Valerie Arboleda, MD PhD
The overarching research goals in the lab is to integrate large-scale data sets to improve our biological understanding and clinical treatment of human disease.
Identification, cloning, regulation and evolution of the two arginases, AI and AII, in man and experimental animals. The goal is to understand the basic biology and pathology of arginine metabolism and then find a treatment for arginase AI deficiency.
Regulation of gene expression in the human arginase system and arginase deficiency; role of arginase in cancer cell proliferation; technical and ethical aspects of molecular genetic screening; development of novel DNA diagnostics.
Dr. Luo is interested in developing and applying new genomic and genetic technologies to address long-standing questions in human diseases including the causal cell type(s) of diseases and the functions of non-coding genetic variants.
During the past few years, we have worked on two general areas, the pathogenesis of hypertriglyceridemia and diseases of the nuclear lamina. Our laboratory works on molecules as they relate to human disease, and we make use of diverse techniques in molecular and cellular biology. When appropriate, we make use of genetically modified mice to investigate our research questions.